In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


WHI calcium/vitamin D arm recruitment expected to improve with swallowable Os-Cal tabs.

This article was originally published in The Tan Sheet

Executive Summary

WOMEN's HEALTH INITIATIVE CALCIUM/VITAMIN D ARM RECRUITMENT is expected to improve with the availability of the swallowable version of SmithKline Beecham's Os-Cal 500+D supplement, according to WHI officials. The company has agreed to supply the swallowable tablets, which are marketed, as an alternative to the chewable version of the supplement that has been offered in the trial. The chewable tablets were made specifically for the study and are not being marketed.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts